Literature DB >> 20421160

Schizophrenia risk factors constitute general risk factors for psychiatric symptoms in the population.

Elemi J Breetvelt1, Marco P M Boks, Mattijs E Numans, Jean-Paul Selten, Iris E C Sommer, Diederick E Grobbee, René S Kahn, Mirjam I Geerlings.   

Abstract

BACKGROUND: The presence of a psychosis continuum is suggested by studies showing that schizophrenia and non-clinical psychotic symptoms in the general population share the same risk factors. However, to our knowledge no large-scale studies have been conducted which examine the specificity of these risk factors in the general population. AIM: To investigate whether socio-demographic characteristics associated with non-clinical psychotic symptoms are also associated with other psychiatric symptoms. And secondly, to examine to what extent concomitant psychiatric symptoms explain the relationship between socio-demographic characteristics and non-clinical psychotic symptoms.
METHODS: In a general population sample of 4894 subjects (mean age 39 years, 45% men) from the Utrecht Health Project we investigated the associations of socio-demographical characteristics with non-clinical psychotic symptoms and other psychiatric symptoms by using the SCL-90. We examined these associations using multivariable logistic regression analyses with and without controlling for the presence of other psychiatric symptoms.
RESULTS: Participants with non-clinical psychotic symptoms had an 89% probability of concomitant depressive, anxiety or phobic anxiety symptoms, compared to 11% in participants without psychotic symptoms. The risk profiles for non-clinical psychotic symptoms and other psychiatric symptoms were largely similar. Non-Dutch ethnicity was most strongly associated with non-clinical psychotic symptoms. Adjusting for other psychiatric symptoms did not increase the specificity of the risk factors.
CONCLUSION: Socio-demographic risk factors for non-clinical psychotic symptoms in the general population are also risk factors for other psychiatric symptoms. The relationship between these risk factors and psychotic symptoms are for a substantial part explained by an increase in other psychiatric symptoms. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20421160     DOI: 10.1016/j.schres.2010.03.033

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  14 in total

1.  Comparison of children with autism spectrum disorder with and without schizophrenia spectrum traits: gender, season of birth, and mental health risk factors.

Authors:  Kenneth D Gadow; Carla J DeVincent
Journal:  J Autism Dev Disord       Date:  2012-11

2.  Heritability and familiality of psychopathologic dimensions in Korean families with schizophrenia.

Authors:  Hwagyu Suh; Byung Dae Lee; Je Min Park; Young Min Lee; Eunsoo Moon; Hee Jeong Jeong; Soo Yeon Kim; Kang Yoon Lee; Young In Chung
Journal:  Psychiatry Clin Neurosci       Date:  2019-02-02       Impact factor: 5.188

3.  Effects of multidimensional treatment foster care on psychotic symptoms in girls.

Authors:  Richie Poulton; Mark J Van Ryzin; Gordon T Harold; Patricia Chamberlain; David Fowler; Mary Cannon; Louise Arseneault; Leslie D Leve
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-09-16       Impact factor: 8.829

4.  Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity--implications for diagnosis and ultra-high risk research.

Authors:  Johanna T W Wigman; Martine van Nierop; Wilma A M Vollebergh; Roselind Lieb; Katja Beesdo-Baum; Hans-Ullrich Wittchen; Jim van Os
Journal:  Schizophr Bull       Date:  2012-01-18       Impact factor: 9.306

5.  Subclinical psychosis syndromes in the general population: results from a large-scale epidemiological survey among residents of the canton of Zurich, Switzerland.

Authors:  W Rössler; V Ajdacic-Gross; H Haker; S Rodgers; M Müller; M P Hengartner
Journal:  Epidemiol Psychiatr Sci       Date:  2013-11-26       Impact factor: 6.892

6.  Psychotic and schizotypal symptoms in non-psychotic patients with obsessive-compulsive disorder.

Authors:  Stian Solem; Kristen Hagen; Christoffer Wenaas; Åshild T Håland; Gunvor Launes; Patrick A Vogel; Bjarne Hansen; Joseph A Himle
Journal:  BMC Psychiatry       Date:  2015-05-28       Impact factor: 3.630

7.  Study protocol for a prospective cohort study examining the predictive potential of dynamic symptom networks for the onset and progression of psychosis: the Mapping Individual Routes of Risk and Resilience (Mirorr) study.

Authors:  Sanne H Booij; Marieke Wichers; Peter de Jonge; Sjoerd Sytema; Jim van Os; Lex Wunderink; Johanna T W Wigman
Journal:  BMJ Open       Date:  2018-01-21       Impact factor: 2.692

8.  Exploratory Factor Analysis of SCL90-R Symptoms Relevant to Psychosis.

Authors:  Jafar Bakhshaie; Vandad Sharifi; Javad Amini
Journal:  Iran J Psychiatry       Date:  2011

9.  Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis.

Authors:  Simon Zhornitsky; Andràs Tikàsz; Élie Rizkallah; Jean-Pierre Chiasson; Stéphane Potvin
Journal:  J Addict       Date:  2015-08-31

10.  Common versus psychopathology-specific risk factors for psychotic experiences and depression during adolescence.

Authors:  D Kounali; S Zammit; N Wiles; S Sullivan; M Cannon; J Stochl; P Jones; L Mahedy; S H Gage; J Heron; G Lewis
Journal:  Psychol Med       Date:  2014-09       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.